Education
About Us
Working with TipRanks
Follow Us
NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ:NTHI
NTHI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.20 - $25.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)195.64K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,026,775
10 Day Avg. Volume490,167
30 Day Avg. Volume195,636
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeOnc Technologies Holdings, Inc. News
PremiumCompany Announcements
NeOnc Technologies Secures $5M Through Convertible Notes
PremiumCompany Announcements
NeOnc Technologies Announces UAE Investment Partnership
PremiumCompany Announcements
NeOnc Technologies Appoints Dr. Josh Neman as CCOOptions Prices
Currently, No data available
---
Ownership Overview
59.59%
Insiders
―
Mutual Funds
0.21% Other Institutional Investors
40.20% Public Companies and
Individual Investors
NTHI FAQ
What was NeOnc Technologies Holdings, Inc.’s price range in the past 12 months?
NeOnc Technologies Holdings, Inc. lowest stock price was $3.20 and its highest was $25.00 in the past 12 months.
What is NeOnc Technologies Holdings, Inc.’s market cap?
Currently, no data Available
When is NeOnc Technologies Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NeOnc Technologies Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is NeOnc Technologies Holdings, Inc. overvalued?
According to Wall Street analysts NeOnc Technologies Holdings, Inc.’s price is currently Overvalued.
Does NeOnc Technologies Holdings, Inc. pay dividends?
NeOnc Technologies Holdings, Inc. does not currently pay dividends.
What is NeOnc Technologies Holdings, Inc.’s EPS estimate?
NeOnc Technologies Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeOnc Technologies Holdings, Inc. have?
NeOnc Technologies Holdings, Inc. has 19,026,775 shares outstanding.
What happened to NeOnc Technologies Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NeOnc Technologies Holdings, Inc.?
Currently, no hedge funds are holding shares in NTHI
Company Description
NeOnc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Technical Analysis
Salarius Pharmaceuticals
―
Windtree Therapeutics
―
Vincerx Pharma Inc
―
GRI Bio
―
Onconetix
―